MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacep.2026.03.002

Медицинская библиотека · JACC. Clinical electrophysiology · 2026

Early U.S. Experience With Catheter Ablation of Ventricular Arrhythmias With a Dual-Energy Lattice-Tip Catheter: Insights From the CLEAR-VT Registry.

Dasa Osama, Younis Arwa, Higuchi Koji, Sroubek Jakub, Lee Justin Z, Chung Roy, Nakhla Shady, Hight Nolan, Varma Niraj, Hussein Ayman A, Taigen Tyler, Kanj Mohamed, Bhargava Mandeep, Saliba Walid I, Wazni Oussama M, Santangeli Pasquale

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Catheter ablation of ventricular arrhythmias (VAs) with conventional small-tip radiofrequency ablation (RFA) catheters is limited by inadequate lesion size and small footprint design.

OBJECTIVES

This early U.S. experience investigated procedural and clinical outcomes of VA ablation with a lattice-tip wide footprint catheter that allows toggling between RFA and pulsed field ablation (PFA).

METHODS

The Cleveland Clinic VT (CLEAR-VT) Registry is a prospectively maintained registry of consecutive patients undergoing catheter ablation of VAs. Patients undergoing catheter ablation of VA with an RFA/PFA lattice-tip catheter (Sphere-9; Medtronic) between January and September 2025 were analyzed.

RESULTS

A total of 59 patients (median age 70 years; mean left ventricular ejection fraction 36.3% ± 12.3%) underwent ablation of VA using the lattice-tip catheter during the study period. Of these, 50 (85%) had scar-related ventricular tachycardia (VT) (28 with ischemic, 19 with nonischemic, and 3 with mixed cardiomyopathy), and 9 (15%) had frequent premature ventricular contractions (PVCs). Acute procedural success, defined as non-inducibility of any VT (excluding nonclinical VTs with cycle length ≤240 milliseconds) or complete PVC suppression, was achieved in 78% and 100% of patients, respectively. After a median follow-up of 100 days (Q1-Q3: 51-172 days), VT recurred in 9 patients (18%), and death/heart transplantation/left ventricular assist device implantation occurred in 6 patients (12%). At 6 months, the Kaplan-Meier-estimated VT-free survival was 69.8% (95% CI: 54.0%-90.3%); the Fine-Gray cumulative incidence of VT recurrence, accounting for competing risks, was 28.4% (95% CI: 11.0%-45.8%). No patient with PVCs had recurrence after a median follow-up of 54 days (Q1-Q3: 40-71 days). Three major procedure-related complications occurred, including 2 major bleeding events and 1 implantable cardioverter-defibrillator system failure after PFA application approximately 7.5 mm from the tip of a left ventricular pacing lead (which required intra-operative device generator change).

CONCLUSIONS

In this first U.S. series, catheter ablation of VAs with a lattice-tip RFA/PFA catheter appeared effective and generally safe. Caution should be exercised when applying PFA in proximity to exposed conductors of implantable cardiac devices.

Для цитирования: Dasa Osama, Younis Arwa, Higuchi Koji, Sroubek Jakub, Lee Justin Z, Chung Roy, Nakhla Shady, Hight Nolan, Varma Niraj, Hussein Ayman A, Taigen Tyler, Kanj Mohamed, Bhargava Mandeep, Saliba Walid I, Wazni Oussama M, Santangeli Pasquale. Early U.S. Experience With Catheter Ablation of Ventricular Arrhythmias With a Dual-Energy Lattice-Tip Catheter: Insights From the CLEAR-VT Registry.. JACC. Clinical electrophysiology. 2026. DOI: 10.1016/j.jacep.2026.03.002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.